Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer

Conditions:   HER2-negative Breast Cancer;   Inflammatory Breast Cancer;   Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast CancerInterventions:   Drug: Romidepsin;   Drug: AbraxaneSponsors:   Thomas Jefferson University;   Celgene CorporationRecruiting - verified May 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials